Sector News

DuPont’s nutritional arm eyed by Royal DSM

September 17, 2019
Chemical Value Chain

DuPont’s nutrition and bioscience business may be up for sale and Amsterdam’s Royal DSM may want to buy it, according to a report from Bloomberg.

Download Now: To be a profitable investor you first need to know the rules. Get Jim Cramer’s 25 Rules for Investing Special Report

The business could be valued at $25 billion, people who asked not to be identified told Bloomberg.

The specialty chemicals maker has been considering the sale or spinoff of its nutrition business, and has been in the process of selecting advisers to sort out offers for the division for some time, according to confidential sources.

In August, Bloomberg said that DuPont wanted to rid itself of the arm, and may be looking into a Reverse Morris Trust, a tax-free merger, as well.

Shares of DuPont fell 1.41% to $72.50 on Monday.

By Cherella Cox Owoyelu

Source: The Street

Related News

July 9, 2020

Europe PE buyers face large hikes in uncertain market

Chemical Value Chain

Polyethylene (PE) buyers face significant increases in the early stages of July discussions, although retroactive business means that final numbers will not be settled for some weeks. The high level […]

July 9, 2020

Ineos to buy BP petrochemicals businesses for $5bn

Chemical Value Chain

BP is selling its remaining standalone petrochemicals businesses to Ineos for $5 billion (£4 billion), as part of a reorganisation aimed at meeting the challenge of a transition to cleaner […]

July 9, 2020

OMV’s second-quarter petchem margin down, refinery utilization plunges

Chemical Value Chain

OMV (Vienna, Austria) says its second-quarter 2020 ethylene/propylene net margin has fallen to €393/metric ton ($445), down from €475/metric ton in the prior-year quarter and €459/metric ton in the first […]